Find policies, billing codes, payers, states, and providers
Loading...
Create a personalized view of the payer policy updates that matter to you and get notified when changes occur.
Start getting alertsCreate a personalized view of the payer policy updates that matter to you and get notified when changes occur.
Start getting alertsFind policies, billing codes, payers, states, and providers
CPT 88230: Lymphocyte Tissue Culture for Nonneoplastic Disorders
CPT-88233-TISSUE-CULTURE-SKIN-SOLID-TISSUE-NONNEOPLASTICCPT 88233: Tissue Culture from Skin or Solid Tissue Biopsy for Nonneoplastic Disorder
CPT-88235-AMNIOTIC-FLUID-CHORIONIC-VILLUS-TISSUE-CULTURECPT 88235: Amniotic Fluid or Chorionic Villus Tissue Culture for Chromosome Analysis
CPT-88237-BONE-MARROW-BLOOD-CELL-CULTURE-NEOPLASTIC-DISORDERCPT 88237: Cell Culture for Bone Marrow or Blood in Neoplastic Disorder
CPT-88239-SOLID-TUMOR-CELL-CULTURE-NEOPLASTIC-DISORDERCPT 88239: Cell Culture From Solid Tumor for Neoplastic Disorder
CPT-88240-CELL-LINE-CRYOPRESERVATION-STORAGECPT 88240: Cryopreservation and Storage of Cell Line
CPT-88241-THAW-AND-EXPAND-FROZEN-CELLS-SINGLE-ALIQUOTCPT 88241: Thaw and Expand Previously Frozen Cells, Single Aliquot
CPT-88245-CHROMOSOME-ANALYSIS-SISTER-CHROMATID-EXCHANGE-SCECPT 88245: Chromosome Analysis for Sister Chromatid Exchange
CPT-88248-CHROMOSOME-ANALYSIS-BREAKAGE-SYNDROMECPT 88248: Chromosome Analysis for Breakage Syndromes
CPT-88249-CHROMOSOME-ANALYSIS-BREAKAGE-SYNDROME-CLASTOGEN-STRESSCPT 88249: Chromosome Analysis for Breakage Syndrome, 100-Cell Clastogen Stress
Showing 1–10 of 27
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.